To: Dan Ross who wrote (20 ) 12/7/1997 6:08:00 AM From: Mike Winn Read Replies (2) | Respond to
Here Dan, I have a good stock for you for next week. Check this SNUS stock out. I think you can make 10% by end of next week. Sonus is a biotech company specializing in contrast agent. This is a chemical that doctors inject into the patient's body to make the ultrasound picture looking as good as an X-Ray or even better. Doctors now can diagnose breast cancer, prostrate cancer, lesion, blah blah blah without any need for operation. With the help of contrast agent, the ultrasound machine will eventually replace the X-Ray, Cat Scan machines and it's much cheaper. Sonus has strategic alliance with Abbott Lab and Daichi in Japan. Check Sonus's web site at sonuspharma.com , it's very impressive. FDA approval should come within a few more months.biz.yahoo.com . Mr McCamant is very effective at promoting biotech stocks and Sonus will be featured in this conference. If we get lucky, this stock can jump from the current share price of $39 to the old 52-week high of $46 7/8. If the stock doesn't fly this time around, then there will be a H&Q health conference in mid January 1998, Sonus will be featured there again, and it should fly like it did last year. Now worse come to worse, if the stock still doesn't fly after those two conferences, then FDA approval should happen in the first quarter of 1998 and the stock must go up. Within the next two years, this stock should be worth at least $100 as there are million of ultrasounds done each year.
